ArticlePharmaceuticals (Basel, Switzerland)2019

Methylxanthines: Potential Therapeutic Agents for Glioblastoma.

Daniel Pérez-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.